“Research suggests that vaccination against COVID via mRNA vaccines may reduce body's ability to produce key type of antibody.”
"The predominance of immune-evading variants among post-vaccination cases indicates possible selective pressure for antibody-resistant escape variants circulating locally over time in the vaccinated population.”
“WHO says SARS-CoV-2 has been detected in a number of the cases, although the data it has is incomplete.”
“Should we be worried? We think so, but not about monkeypox itself. Much more about what the WHO and collaborating institutions, governments and corporations are up to. A lot of ‘truth seekers’ will have already found out about the WHO tabletop exercise in 2021and it is without doubt interesting that the 15 May 2022 date is given as the 'attack' date of the monkeypox outbreak.”
“For the third year, Americans are greeting the unofficial start of summer shadowed by the specter of the coronavirus amid rising covid-19 cases and hospitalizations across the country. The United States is recording more than 100,000 infections a day — at least five times higher than this point last year.”
Geert Vanden Bossche received his DVM from the University of Ghent, Belgium, and his PhD degree in Virology from the University of Hohenheim, Germany. He held adjunct faculty appointments at universities in Belgium and Germany. After his career in Academia, Geert joined several vaccine companies (GSK Biologicals, Novartis Vaccines, Solvay Biologicals) to serve various roles in vaccine R&D as well as in late vaccine development.
Geert then moved on to join the Bill & Melinda Gates Foundation’s Global Health Discovery team in Seattle (USA) as Senior Program Officer; he then worked with the Global Alliance for Vaccines and Immunization (GAVI) in Geneva as Senior Ebola Program Manager. At GAVI he tracked efforts to develop an Ebola vaccine. He also represented GAVI in fora with other partners, including WHO, to review progress on the fight against Ebola and to build plans for global pandemic preparedness.
Back in 2015, Geert scrutinized and questioned the safety of the Ebola vaccine that was used in ring vaccination trials conducted by WHO in Guinea. His critical scientific analysis and report on the data published by WHO in the Lancet in 2015 was sent to all international health and regulatory authorities involved in the Ebola vaccination program. After working for GAVI, Geert joined the German Center for Infection Research in Cologne as Head of the Vaccine Development Office. He is at present primarily serving as a Biotech / Vaccine consultant while also conducting his own research on Natural Killer cell-based vaccines.